Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/1015
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2025-03-06T03:43:07Z-
dc.date.available2025-03-06T03:43:07Z-
dc.date.issued2024-03-16-
dc.identifier.issn2749-3644-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/1015-
dc.description.abstractHepatotoxicity is damage caused by exposure to a drug or non- pharmacological agents. Risk factors include: individual intolerance, age, gender, alcohol consumption, smoking, concomitant use of other drugs, liver disease, genetic and environmental factors. [1–3] Although most lipophilic drugs can cause hepatotoxicity , [4] antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants are the pharmacological groups that are the most common causes. [1, 5-9]. Among the drugs administered intravenously, antibiotics and neoplasia drugs are mostly associated with liver toxicityen_US
dc.language.isoenen_US
dc.publisherWorld Bulletin of Public Health (WBPH)en_US
dc.relation.ispartofseriesvolume-32;-
dc.subjectHepatotoxicity, intolerance, age, gender, alcohol consumption, smoking, concomitant use of other drugs, liver disease, genetic and environmental factors.en_US
dc.titleNEW APPROACHES IN THE TREATMENT OF METABOLIC DISORDERS IN LIVER FAILUREen_US
dc.typeArticleen_US
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
NEW APPROACHES IN THE TREATMENT OF METABOLIC DISORDERS IN LIVER FAILURE.pdf223.24 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.